Fortrea Holdings Inc. (FTRE) is the 17th largest of 41 Contract Research companies by market capitalisation, at 1.73 Bn, behind Neogenomics Inc at 2.23 Bn. The table below compares all 41 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IQV | Iqvia Holdings Inc. | primary | H-11 | Pharma Services | HG-03 | 44.19 Bn | 33.48 | 2.60 | 42.11 Bn |
| 2 | MEDP | Medpace Holdings, Inc. | primary | H-11 | Pharma Services | HG-03 | 16.72 Bn | 34.02 | 6.01 | 16.22 Bn |
| 3 | CRL | Charles River Laboratories International, Inc. | primary | H-11 | Pharma Services | HG-03 | 13.89 Bn | -58.45 | 3.47 | 13.70 Bn |
| 4 | ICLR | Icon Plc | primary | H-11 | Pharma Services | HG-03 | 12.81 Bn | 16.47 | 1.55 | 12.81 Bn |
| 5 | FTRE | Fortrea Holdings Inc. | primary | H-11 | Pharma Services | HG-03 | 1.73 Bn | -20.27 | 0.65 | 1.56 Bn |
| 6 | EVO | Evotec SE | primary | H-11 | Pharma Services | HG-03 | 0.66 Bn | — | — | 0.23 Bn |
| 7 | DNA | Ginkgo Bioworks Holdings, Inc. | primary | H-11 | Pharma Services | HG-03 | 0.43 Bn | -1.47 | 3.82 | 0.34 Bn |
| 8 | CSBR | Champions Oncology, Inc. | primary | H-11 | Pharma Services | HG-03 | 0.07 Bn | -61.57 | 1.22 | 0.07 Bn |
| 9 | HYFT | MindWalk Holdings Corp. | primary | H-11 | Pharma Services | HG-03 | 0.06 Bn | -10.10 | 5.47 | 0.05 Bn |
| 10 | VIVS | VivoSim Labs, INC. | primary | H-11 | Pharma Services | HG-03 | 0.00 Bn | -0.13 | 13.19 | 0.00 Bn |
| 11 | NOTVQ | Inotiv, Inc. | primary | H-11 | Pharma Services | HG-03 | 0.00 Bn | 0.00 | 0.00 | -0.01 Bn |
| 12 | TMO | Thermo Fisher Scientific Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 226.11 Bn | 32.12 | 4.88 | 222.04 Bn |
| 13 | LH | Labcorp Holdings Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 26.87 Bn | 26.77 | 1.87 | 26.72 Bn |
| 14 | GH | Guardant Health, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 20.84 Bn | -45.97 | 17.62 | 19.79 Bn |
| 15 | LDOS | Leidos Holdings, Inc. | secondary | I-02 | Aerospace and Defense | IG-01 | 16.74 Bn | 12.00 | 0.95 | 16.00 Bn |
| 16 | DVA | Davita Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 11.79 Bn | 10.12 | 0.84 | 11.10 Bn |
| 17 | TEM | Tempus AI, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 11.59 Bn | -46.65 | 8.09 | 10.77 Bn |
| 18 | RDY | Dr Reddys Laboratories Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 9.91 Bn | 785.46 | 2.70 | 9.74 Bn |
| 19 | TWST | Twist Bioscience Corp | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 7.82 Bn | -57.20 | 18.11 | 7.65 Bn |
| 20 | CAI | Caris Life Sciences, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 6.99 Bn | 66.50 | 7.07 | 6.20 Bn |
| 21 | ADPT | Adaptive Biotechnologies Corp | secondary | H-17 | Healthcare Providers | HG-04 | 3.86 Bn | -95.86 | 12.53 | 3.51 Bn |
| 22 | ABCL | AbCellera Biologics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.49 Bn | -21.19 | 52.73 | 3.49 Bn |
| 23 | NEO | Neogenomics Inc | secondary | H-17 | Healthcare Providers | HG-04 | 2.23 Bn | -43.04 | 2.91 | 2.09 Bn |
| 24 | STLN | Starling Oncology, Inc. | secondary | H-14 | Healthcare Providers | HG-04 | 0.61 Bn | -20.06 | 1.04 | 0.57 Bn |
| 25 | OABI | OmniAb, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.59 Bn | -13.32 | 15.34 | 0.54 Bn |
| 26 | CLPT | ClearPoint Neuro, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.42 Bn | -14.36 | 9.90 | 0.39 Bn |
| 27 | WDH | Waterdrop Inc. | secondary | F-16 | Insurance | FG-04 | 0.39 Bn | 4.88 | 0.61 | 0.26 Bn |
| 28 | IMRX | Immuneering Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.31 Bn | -5.33 | — | 0.31 Bn |
| 29 | BDSX | Biodesix Inc | secondary | H-17 | Healthcare Providers | HG-04 | 0.27 Bn | -9.35 | 2.61 | 0.24 Bn |
| 30 | YDES | YD Bio Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.24 Bn | -19.42 | 287.04 | 0.24 Bn |
| 31 | AGPU | Axe Compute Inc. | secondary | T-44 | Cloud Computing | TG-07 | 0.20 Bn | -7.88 | — | 0.17 Bn |
| 32 | XGN | Exagen Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 0.18 Bn | -9.59 | 2.55 | 0.16 Bn |
| 33 | KRMD | KORU Medical Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.15 Bn | -63.03 | 3.28 | 0.14 Bn |
| 34 | IMDX | Insight Molecular Diagnostics Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.15 Bn | -2.71 | 88.02 | 0.13 Bn |
| 35 | MXCT | Maxcyte, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.14 Bn | -3.87 | 4.44 | 0.14 Bn |
| 36 | BNR | Burning Rock Biotech Ltd | secondary | H-17 | Healthcare Providers | HG-04 | 0.10 Bn | -11.34 | 1.25 | 0.03 Bn |
| 37 | XBIT | XBiotech Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -1.62 | — | 0.07 Bn |
| 38 | NTRB | NutriBand Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -2.25 | 37.29 | 0.06 Bn |
| 39 | PBSV | Pharma-Bio Serv, Inc. | secondary | I-26 | Business Services | IG-06 | 0.01 Bn | 220.48 | 1.26 | 0.00 Bn |
| 40 | BFRG | BullFrog AI Holdings, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.62 | 28.60 | 0.00 Bn |
| 41 | CPMV | Mosaic ImmunoEngineering Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.27 | — | 0.00 Bn |